Background: Environmental factors may influence the lifetime risk of cancer (penetrance) in women with a BRCA mutation. Materials and Methods: In 89 BRCA-mutant women, affected or unaffected by breast/ovarian cancer, we explored serum levels of adipokines and their relation with the polymorphism SNP276G>T as modulators of BRCA penetrance. Results: Affected women had significantly lower adiponectin than healthy women. Affected women with rs1501299 TT had significantly lower adiponectin and higher leptin than GT and GG genotypes. GT genotype was significantly associated with the disease status [odds ratio (OR)=3.24, 95% confidence interval (95% CI)=1.03-10.17]. Women in the lower tertile of serum adiponectin had a RR of BRCA-associated cancer of 2.80, 95% CI=1.1-7.1 (p for trend=0.03) compared with women in the higher tertile. Conclusion: In the SNP rs1501299 the T allele was significantly associated with lower serum levels of adiponectin in affected women, suggesting that the T allele might be related to cancer. Women who inherit a germ-line BRCA1 or BRCA2 mutation face a high lifetime cumulative risk (penetrance) of developing breast cancer (BC), in the order of 55% compared to 12% in the general population, and ovarian cancer (OC) in the order of 16-59% (1-4). Given the incomplete penetrance, it has been suggested that several factors, genetic (polymorphisms) and/or "environmental", may influence BRCA penetrance. The cancer risk is higher if genotype carriers are obese or have a high energy intake and lifelong weight gain (5-8). Obesity may affect BRCA penetrance through a number of mechanisms including insulin resistance, induction of a metabolic syndrome, chronic low-grade inflammation and insulin-like growth factor I (IGF-I) regulation. Metabolic syndrome and diabetes are also associated with hereditary BC (6, 9). A case-control analysis of 308 high genetic-risk women showed that high serum levels of IGF-I were associated with significantly greater penetrance (10). Body weight is regulated by leptin and adiponectin, two adipokines that have pathological signaling cascades in relation to the pathogenesis of various diseases, including cancer (11-20). Leptin is an adipokine produced in white adipose tissue that controls appetite and energy balance, increases with BMI (16) and is linked epidemiologically with obesity-related cancers, including sporadic BC risk (13, 21). Adiponectin, an adipose-derived protein of 244 amino acids, is an endogenous insulin sensitizer that also regulates the secretion of estrogens, TNF-α and IGF-I (11, 14). It has an inverse relationship with adiposity, so its levels are low in obese and diabetic subjects, with a stronger negative correlation with visceral adiposity (16). Adiponectin is inversely related to the risk of obesity-related cancers, including sporadic BC, even after controlling for BMI or other anthropometric markers (18).